Literature DB >> 16091206

The role of the FOXP3 transcription factor in the immune regulation of allergic asthma.

Carsten B Schmidt-Weber1, Kurt Blaser.   

Abstract

Unbalanced immune reactions against allergens are caused by Th2 cells, which are the basis of immunoglobulin E (IgE)-mediated symptoms of allergy and asthma. Although Th2 cells are essential for allergy, they are not sufficient to cause disease, because regulatory T cells (Tregs) control their activity and expansion. Therefore, Tregs are assumed to play an important role not only in the sensitization but also in established allergic disease under therapy. A key factor of Tregs is FOXP3, which, upon expression, is sufficient to induce regulatory T-cell phenotypes. The initiation and suppressive function of FOXP3 and Tregs in the context of allergic asthma are discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16091206     DOI: 10.1007/s11882-005-0006-z

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  59 in total

1.  Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen.

Authors:  Tse-Ching Chen; Stephen P Cobbold; Paul J Fairchild; Herman Waldmann
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  Role of LAG-3 in regulatory T cells.

Authors:  Ching-Tai Huang; Creg J Workman; Dallas Flies; Xiaoyu Pan; Aimee L Marson; Gang Zhou; Edward L Hipkiss; Sowmya Ravi; Jeanne Kowalski; Hyam I Levitsky; Jonathan D Powell; Drew M Pardoll; Charles G Drake; Dario A A Vignali
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

3.  Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.

Authors:  H L Weiner
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

4.  TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression.

Authors:  V L Heath; E E Murphy; C Crain; M G Tomlinson; A O'Garra
Journal:  Eur J Immunol       Date:  2000-09       Impact factor: 5.532

5.  JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome.

Authors:  T A Chatila; F Blaeser; N Ho; H M Lederman; C Voulgaropoulos; C Helms; A M Bowcock
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

6.  Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist.

Authors:  Chia-Huey Lin; Thomas Hünig
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

7.  Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma.

Authors:  Christian Karagiannidis; Mübeccel Akdis; Päivi Holopainen; Niina J Woolley; Gabriele Hense; Beate Rückert; Pierre-Yves Mantel; Günther Menz; Cezmi A Akdis; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

Review 8.  Immunological mechanisms in specific immunotherapy.

Authors:  Carsten B Schmidt-Weber; Kurt Blaser
Journal:  Springer Semin Immunopathol       Date:  2003-10-24

9.  Interleukin-10 suppresses proliferation and remodeling of extracellular matrix of cultured human skin fibroblasts.

Authors:  A Moroguchi; K Ishimura; K Okano; H Wakabayashi; T Maeba; H Maeta
Journal:  Eur Surg Res       Date:  2004 Jan-Feb       Impact factor: 1.745

10.  Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.

Authors:  Hélène Bour-Jordan; Benoît L Salomon; Heather L Thompson; Gregory L Szot; Matthew R Bernhard; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

View more
  8 in total

1.  Semaphorin 3A Is Effective in Reducing Both Inflammation and Angiogenesis in a Mouse Model of Bronchial Asthma.

Authors:  Sabag D Adi; Nasren Eiza; Jacob Bejar; Hila Shefer; Shira Toledano; Ofra Kessler; Gera Neufeld; Elias Toubi; Zahava Vadasz
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

Review 2.  [Immunological principles of allergen-specific immune therapy].

Authors:  K Blaser
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

Review 3.  [T-cell immune responses in chronic inflammatory diseases of the nasal mucosa].

Authors:  L Klimek; I Casper; S Siemer; B Wollenberg; R Stauber; M Koennecke
Journal:  HNO       Date:  2019-11       Impact factor: 1.284

4.  [Allergen specific immunotherapy for rhinitis allergica : New applications].

Authors:  L Klimek; T Kündig; G Senti
Journal:  HNO       Date:  2015-05       Impact factor: 1.284

5.  The Effect of Adenosine A2A and A2B Antagonists on Tracheal Responsiveness, Serum Levels of Cytokines and Lung Inflammation in Guinea Pig Model of Asthma.

Authors:  Laleh Pejman; Hasan Omrani; Zahra Mirzamohammadi; Amir Ali Shahbazfar; Majid Khalili; Rana Keyhanmanesh
Journal:  Adv Pharm Bull       Date:  2013-12-24

Review 6.  OX40/OX40 ligand interactions in T-cell regulation and asthma.

Authors:  Davinder Kaur; Christopher Brightling
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

7.  Age-related immune-modulating properties of seminal fluid that control the severity of asthma are gender specific.

Authors:  Yuichi Niikura; Takashi Ishii; Jurika Murakami; Tomoya Narita; Yoko Fujita; Hiroaki Negishi; Yuji Taketani; Naomi Yamashita
Journal:  Aging (Albany NY)       Date:  2019-01-24       Impact factor: 5.682

8.  The effect of single dose of thymoquinone, the main constituents of Nigella sativa, in guinea pig model of asthma.

Authors:  Rana Keyhanmanesh; Laleh Pejman; Hasan Omrani; Zahra Mirzamohammadi; Amir A Shahbazfar
Journal:  Bioimpacts       Date:  2014-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.